---
title: "Terns Pharma: I Don't See The Positioning"
date: "2025-02-08 12:44:16"
summary: "Pgiam/iStock via Getty Images  I covered Terns (NASDAQ:TERN) twice in the last 3 years, both were negative articles, and the stock hasn’t done too well since those articles. However, there was some positive data from last year, and a few other"
categories:
  - "seekalpha_articles"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha_articles"
menu: ""
thumbnail: "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1220627489/image_1220627489.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

![Business on Wall Street in Manhattan](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1220627489/image_1220627489.jpg?io=getty-c-w750) 



Pgiam/iStock via Getty Images





I covered Terns (NASDAQ:[TERN](https://seekingalpha.com/symbol/TERN "Terns Pharmaceuticals, Inc.")) [twice](https://seekingalpha.com/article/4639703-terns-pharma-business-model-not-impress) in the [last](https://seekingalpha.com/article/4564393-terns-pharmaceuticals-no-real-product-differentiation) 3 years, both were negative articles, and the stock hasn’t done too well since those articles. However, there was some positive data from last year, and a few other

[seekalpha_articles](https://seekingalpha.com/article/4756323-terns-pharma-i-dont-see-the-positioning)
